Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2026 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de serviceAcceptable Use
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to Reports
Fundraising

Antithesis

Antithesis Raises $105 million in Series A

Northern VirginiaDecember 3, 20252 min read
Total Raised
105 million
Valuation
Undisclosed
Latest Round
Series A
Employees
150+

Antithesis Raises $105 million in Series A


Antithesis has successfully raised $105 million in a Series A at a Undisclosed led by Jane Street.


Company Overview


Antithesis is a Enterprise Software company headquartered in Northern Virginia, founded in 2018 with 150+ employees.


Antithesis conducts a fully deterministic massively parallel simulation that tests years of real-world production in a few hours. The platform helps companies test complex distributed software systems and has increased revenue by over 12x over the last two years.


Fundraising Details


  • Amount Raised: $105 million
  • Round Type: Series A
  • Valuation: Undisclosed
  • Date: 2025-12-03
  • Investors: Jane Street and Amplify Venture Partners and Spark Capital and Tamarack Global and First In Ventures and Teamworthy Ventures and Hyperion Capital

About Antithesis


Antithesis conducts a fully deterministic massively parallel simulation that tests years of real-world production in a few hours. The platform helps companies test complex distributed software systems and has increased revenue by over 12x over the last two years. The company is positioned in the Enterprise Software sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Northern Virginia
  • Founded: 2018
  • Team Size: 150+
  • Industry: Enterprise Software

What This Means


This funding round demonstrates strong investor confidence in Antithesis's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Enterprise Software sector continues to attract significant investment as companies innovate to meet evolving market demands. Antithesis's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching Undisclosed marks an important milestone for Antithesis, positioning the company among notable players in the Enterprise Software industry.


Looking Ahead


With this new capital, Antithesis is well-positioned to execute on its growth strategy and continue building innovative solutions in the Enterprise Software space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-12-03. For more information about Antithesis, visit their headquarters at Northern Virginia.

Company Info

Headquarters
Northern Virginia
Founded
2018
Team Size
150+
Last Round
105 million(Dec 2025)

Investors (7)

J
Jane StreetLead
Venture Capital
Investor in Antithesis
A
Amplify Venture Partners
Venture Capital
Investor in Antithesis
S
Spark Capital
Venture Capital
Investor in Antithesis
T
Tamarack Global
Venture Capital
Investor in Antithesis
F
First In Ventures
Venture Capital
Investor in Antithesis
T
Teamworthy Ventures
Venture Capital
Investor in Antithesis
H
Hyperion Capital
Venture Capital
Investor in Antithesis

Topics

Fundraising(2912)Enterprise Software(383)Series AAntithesis2025

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free